S25-024 Extracellular vesicles as modulators of immune responses to Adeno-Associated Virus (AAV) gene therapy vectors Stanford researchers have developed a novel technology using extracellular vesicles (EVs) to selectively suppress immune responses to AAV vectors, enabling safer and more effective gene therapy. Bradley Hamilton Casey Maguire